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ene targeting has indicated that the bHLH transcription factors Myf-5 and MyoD are required for myogenic determination
ecause skeletal myoblasts and myofibers are entirely ablated in mouse embryos lacking both Myf-5 and MyoD. Entrance
nto the skeletal myogenic program during development occurs following the independent transcriptional induction of
ither Myf-5 or MyoD. To identify sequences required for the de novo induction of MyoD transcription during development,
we investigated the expression patterns of MyoD-lacZ transgenes in embryos deficient in both Myf-5 and MyoD. We
observed that a 258-bp fragment containing the core of the 220-kb MyoD enhancer activated expression in newly formed
somites and limb buds in compound mutant embryos lacking both Myf-5 and MyoD. Importantly, Myf-5- and MyoD-
deficient presumptive muscle precursor cells expressing b-galactosidase were observed to assume nonmuscle fates primarily
s precartilage primordia in the trunk and the limbs, suggesting that these cells were multipotential. Therefore, cells are
ecruited into the MyoD-dependent myogenic lineage through activation of the 220-kb MyoD enhancer and this occursindependently in somites and limb buds. © 1999 Academic Press
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1INTRODUCTION
The myogenic regulatory factors (MRFs), a group of basic
helix–loop–helix (bHLH) transcription factors composed of
Myf-5, MyoD, myogenin, and MRF4, function to regulate
the development of the embryonic lineage that gives rise to
skeletal muscle. The different roles played by the MRFs
during embryogenesis have been elucidated in gene-
targeting experiments and suggest a division of the MRFs
into two functional groups (reviewed by Rudnicki and
Jaenisch, 1995; Megeney and Rudnicki, 1995). The primary
MRFs, MyoD and Myf-5, are required for the determination
of myoblasts (Rudnicki et al., 1992, 1993; Braun et al.,
992). The secondary MRFs, myogenin and MRF4, act later
n the program as differentiation factors (Hasty et al., 1993;
abeshima et al., 1993; Patapoutian et al., 1995; Zhang et
l., 1995).
Gene-targeting experiments have revealed that Myf-5u
a
1 To whom correspondence should be addressed. Fax: 905-521-
2955. E-mail: rudnicki@mcmaster.ca.
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uring development and that activation of either Myf-5 or
yoD allows entry into the myogenic program (Rudnicki
t al., 1992, 1993; Braun et al., 1992). However, the
egulatory sequences that control the de novo induction
f Myf-5 and MyoD transcription have not been defined.
nalysis of Myf-5 regulatory regions has been problem-
tic because of close proximity to the MRF4 gene and an
pparent overlap in cis-regulatory elements (Patapoutian
t al., 1995; Olson et al., 1996). By contrast, transgenic
nd transfection analyses of MyoD upstream sequences
ave indicated that several regions, including at least two
nhancers, are involved in regulating MyoD transcription
see Fig. 1). Located about 220 kb upstream from the
ranscription start site is a strong enhancer with a func-
ional core sequence of 258 bp capable of directing
ppropriate muscle-specific expression during develop-
ent (Goldhamer et al., 1992, 1995; Faerman et al.,
995). A second MyoD enhancer located about 25 kb
pstream from the transcription start site also directs
ppropriate expression but in a subset of myogenic cells
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220 Kablar et al.that appear to be more differentiated (Tapscott et al.,
992; Asakura et al., 1995, Kablar et al., 1997).
The molecular mechanisms that first activate Myf-5
nd MyoD transcription in an uncommitted mesenchy-
al stem cell during embryogenesis has remained an
nresolved problem. To determine whether either MyoD
nhancer was sufficient for the de novo activation of
yoD transcription, we bred transgenic mice carrying
ifferent MyoD enhancer and promoter regions linked to
acZ with Myf-5 and MyoD mutant mice. The entire
mbryonic lineage that gives rise to skeletal muscle is
blated in animals lacking both Myf-5 and MyoD, as
videnced by the absence of myoblasts and myofibers
hroughout development (Rudnicki et al., 1993; B. Kablar
nd M. A. Rudnicki, unpublished observations). There-
ore, our prediction was that MRF-independent regula-
ory sequences would activate lacZ expression in a tran-
ient manner in the somitic regions of embryos as axial
omites are believed to be the source of all committed
yogenic precursor cells in the trunk and limbs (Haus-
hka, 1994; Ordahl and Le Douarin, 1992; Cossu et al.,
996).
A 258-bp fragment containing the core of the 220-kb
yoD enhancer activated expression in newly formed
omites and limb buds in embryos lacking both Myf-5 and
yoD. The 25-kb MyoD enhancer displayed no such activ-
ty. Therefore, these experiments define the regulatory
equences, a 258-bp fragment containing the core of the
20-kb MyoD enhancer, through which MyoD transcrip-
ion is activated to recruit multipotential mesenchymal
tem cells into the MyoD-dependent myogenic program.
e also observed that lacZ-expressing cells become inte-
rated into cartilage primordia only in embryos deficient for
oth Myf-5 and MyoD . Therefore, we conclude that these
FIG. 1. Structure of the MyoD gene and MyoD-lacZ transgenes. (A
two distal regulatory enhancers located at 25 and 220 kb upstre
equence upstream of the MyoD transcription start site and includ
ontains the 2.5 kb of the proximal MyoD promoter and the 258-bells remain multipotential in the absence of myogenic
actor expression. r
Copyright © 1999 by Academic Press. All rightMATERIALS AND METHODS
Interbreeding and Collection of Embryos
The MD6.0-lacZ transgenic mice carry a construct in which 6.0
kb of MyoD sequence upstream from the transcription start site is
linked to the bacterial lacZ gene (Asakura et al., 1995; see Fig. 1).
The 258/22.5lacZ transgenic mice carry a construct in which the
258-bp core of the 220-kb MyoD enhancer is linked to 2.5 kb of
MyoD sequence upstream of the transcription start site upstream
of the lacZ gene (Goldhamer et al., 1995; see Fig. 1). The lacZ
ransgenic mice were first bred with MyoD2/2 mice (Rudnicki et
l., 1992) to generate MyoD1/2:lacZ mice which were subse-
uently interbred with Myf-51/2 mice (Braun et al., 1992) to
generate Myf-51/2:MyoD1/2:lacZ mice. Myf-51/2:MyoD1/2:
lacZ mice were interbred to obtain embryos of nine different
genotypes as described in Rudnicki et al. (1993). Embryos and the
fetal portion of the placenta were collected by cesarean section
between 10.5 to 13.5 days postcoitum (dpc), embryos were fixed
and stained, and DNA was isolated from the fetal placenta.
Genomic DNA was isolated from the fetal placenta using the
procedure of Laird et al. (1991). Embryos were genotyped by
Southern analysis (Sambrook et al., 1989) of placental DNA using
Myf-5-, MyoD-, and lacZ-specific probes as described previously
(Rudnicki et al., 1993).
b-Galactosidase Staining, Immunohistochemistry,
and TUNEL Analysis of Embryos
b-Galactosidase expression was detected as described by
Asakura et al. (1995). Embryos were fixed 1–2 h (2% paraformal-
dehyde, 0.2% glutaraldehyde, 0.1 M phosphate buffer, pH 7.4, and
2 mM MgCl2) and washed twice for 30 min in solution A (0.1 M
hosphate buffer, pH 7.4, 2 mM MgCl2, 0.1% sodium deoxy-
cholate, 0.2% Nonidet P-40) and then washed twice, for 30 min in
solution B (0.1 M phosphate buffer, pH 7.4, 2 mM MgCl2, 0.01%
odium deoxycholate, 0.2% Nonidet P-40). b-Galactosidase was
detected by overnight incubation at 37°C in 1.0 mg/ml X-gal
regulatory sequences of MyoD consist of a proximal promoter and
rom the transcription start site. (B) MD6.0-lacZ contains 6 kb of
e 25-kb MyoD enhancer (Asakura et al., 1995). (C) 258/22.5lacZ
re of the -20 kb MyoD enhancer (Goldhamer et al., 1995).) The
am f(5-bromo-4-chloro-3-indolyl-b -D-galactoside), 5 mM potassium fer-
icyanide, and 5 mM potassium ferrocyanide. Embryos were
s of reproduction in any form reserved.
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221Activation of MyoD Transcriptionwashed twice for 1 h at room temperature in phosphate-buffered
aline (PBS) and then postfixed overnight, as described above.
mbryos were washed twice for 1 h at room temperature in PBS and
hen stored at 4°C in 70% ethanol. At least three embryos of each
enotype, containing two alleles of the lacZ transgene, were
erived and characterized. Whole embryos were photographed in
0% ethanol using a Zeiss dissecting microscope. Embryos were
mbedded in paraffin and 20-mm sections mounted on slides and
counterstained with eosin.
Immunohistochemistry was performed as previously described
(Rudnicki et al., 1993) on paraffin-embedded 4-mm sections with
ouse monoclonal anti-fetal proteoglycan antibody (Chemicon
nternational Inc.) reactive with cartilage primordial cells of fetal
tage embryos (Glant et al., 1986).
To detect apoptotic nuclei in situ by TUNEL (Gavrieli et al.,
992), we employed the ApopTag detection system (Genzyme).
ections were incubated with terminal deoxynucleotidyl trans-
erase (TdT enzyme) diluted in the reaction buffer. The enzyme
atalyzes a template independent addition of deoxyribonucleotide
riphosphate to the 39-OH ends of double- or single-stranded DNA.
he incorporated nucleotides form a random heteropolymer of
igoxygenin-11–dUTP and dATP that has a reaction site for anti-
igoxigenin antibody carrying a conjugated peroxidase enzyme.
he localized peroxidase enzyme was visualized by a chromogenic
eaction with AEC and sections were counterstained with Gill’s
ematoxylin. The sections were examined and photographed using
Zeiss microscope.
Whole-Mount in Situ Hybridization
Expression of the Pax-3 gene was analyzed by in situ hybrid-
ization using a 520-bp HindIII/PstI fragment of the cDNA
encoding the 39 part of the paired-type homeodomain and most
of the carboxyterminus (Goulding et al., 1994). Mouse embryos
were collected and treated as described by Wilkinson (1992).
Synthesis of sense and antisense digoxigenin-labeled RNA
probes was performed using a DIG RNA labeling kit (Boehringer
Mannheim) according to the manufacturer’s instructions. Whole
FIG. 2. The MD6.0-lacZ transgene, containing the 25-kb Myo
myogenesis. In wild-type embryos, the MD6.0-lacZ transgene was
dpc (C), wild-type expression was apparent throughout the trunk (
and 13.5 dpc (G), wild-type expression was observed in all muscle-f
By contrast, no expression of MD6.0-lacZ was detected in develop
(green arrow) or limbs (yellow arrowhead) except for ectopic expres
al., 1995).
FIG. 3. The 258/22.5lacZ transgene, containing the 220-kb MyoD
embryos. In 10.5-dpc wild-type embryos (A), the 258/22.5lacZ trans
myotomal lips, as well as in limb buds (yellow arrowhead). In 11.5-
aspects of the myotome (green and red arrows, respectively), and con
By 12.5 dpc (I) and 13.5 dpc (M), lacZ expression allowed individua
expression was virtually identical to wild-type (B, F, J, N). In Myf-5
the dorsal and ventral regions with the bar absent from the barbell
Myf-52/2:MyoD2/2 embryos (D) weak lacZ expression was obser
(yellow arrowhead). In 11.5-dpc Myf-52/2:MyoD2/2 embryos (H
(green arrow), but robust expression was observed in the limb bud
observed in the dorsal aspect of dermamyotomal regions (green ar
arrowhead). Expression was also detected in ventral regions of 11.5- and
the transgene was ectopically expressed in the nasal pit of all embryos
Copyright © 1999 by Academic Press. All rightembryos were photographed in 70% ethanol using a Zeiss
dissecting microscope. Care of animals was in accordance with
institutional guidelines.
RESULTS
The 25-kb MyoD Enhancer Is Inactive in Embryos
Lacking Muscle
The MD6.0-lacZ transgene contains 6 kb of MyoD up-
stream regulatory sequences including a potent muscle-
specific enhancer located about 5 kb upstream from the
MyoD transcription start site (Tapscott et al., 1992;
Asakura et al., 1995). Expression of the MD6.0-lacZ trans-
gene appears to closely follow myogenic development and
expression occurs during the differentiation of embryonic
myocytes (Asakura et al., 1995; Kablar et al., 1997).
Wild-type embryos carrying the MD6.0-lacZ transgene
(Asakura et al., 1995) (Fig. 1) exhibited lacZ expression at
10.5 dpc in myotomal regions rostral to the forelimb buds in
the cervical or neck region (Fig. 2A, green arrow). By 11.5
dpc, the MD6.0-lacZ transgene was expressed in myotomal
regions along the entire rostral–caudal axis of the embryo
(Fig. 2C, green arrows), and this expression was expanded
along the rostral–caudal axis in 12.5 dpc (Fig. 2E, green
arrow) and 13.5 dpc embryos (Fig. 2G, green arrow). Expres-
sion in the forelimb buds (yellow arrowhead) was first
observed at 11.5 dpc (compare Figs. 2A and 2C, yellow
arrowhead), and in the hindlimbs by 12.5 dpc (Fig. 2E).
Ectopic expression of the MD6.0-lacZ transgene was ob-
served in the neural tube and spleen of all 10.5 and 11.5 dpc
embryos (Fig. 2) as described elsewhere (Asakura et al.,
1995).
In embryos lacking both Myf-5 and MyoD (designated
Myf-52/2:MyoD2/2), expression of the MD6.0-lacZ trans-
hancer, is not activated in mutant embryos failing to undergo
expressed at 10.5 dpc (A) in cervical regions (green arrow). By 11.5
arrows) and in forelimb buds (yellow arrowhead). By 12.5 dpc (E)
ng areas of the trunk (green arrow) and limbs (yellow arrowheads).
yf-52/2:MyoD2/2 embryos (B, D, F, and H) in either the trunk
in the spleen and neural tube as described previously (Asakura et
ancer, is activated in presumptive muscle forming areas in mutant
was expressed in both dorsal (green arrows) and ventral (red arrow)
ild-type embryos (E), lacZ expression joined the dorsal and ventral
ed strong expression was observed in limb buds (yellow arrowhead).
scle masses to be discerned. In MyoD2/2 embryos the pattern of
embryos, the distribution of myotomal expression was limited to
rn typical of wild-type myotomal regions (C, G, K, O). In 10.5-dpc
nly in posterior somitic regions (green arrow) and not in limb buds
ntinued weak expression was observed in caudal somitic regions
llow arrowhead). By 12.5 dpc (L) and 13.5 dpc (P), expression was
), whereas reduced expression was observed in limb buds (yellowD en
first
green
ormi
ing M
sion
enh
gene
dpc w
tinu
l mu
2/2
patte
ved o
), co
s (ye
rows12.5-dpc embryos (red arrows in H and L). As described previously,
(Goldhamer et al., 1995).
s of reproduction in any form reserved.
222 Kablar et al.Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
(
2
e
v
s
d
B
m
i
l rows
g
223Activation of MyoD Transcriptiongene was not observed in presumptive myotomal regions or
in the limb buds between 10.5 and 13.5 dpc (Fig. 2, compare
FIG. 4. Sites of 258/22.5lacZ transgene expression in 11.5-dpc
mbryos, lacZ expression (arrows) was observed in thoracic myoto
entral dermamyotomal regions in tail somites (E). In 11.5-dpc M
omitic regions (asterisk in B) but was evident in presumptive musc
ermomyotome in tail somites (F). Ectopic transgene expression w
y 12.5 dpc, wild-type embryos (G) exhibited extensive formation
utant embryos (H), a rosette of lacZ-expressing cells was observed
n the trunk (J) and in a dispersed pattern of cells in putative mu
acZ-expressing rosette of cells in wild-type embryos (compare ar
anglia; h, humerus primordia; mt, myotome; nt, neural tube.A, C, E, and G with B, D, F, and H). Only areas of
MD6.0-lacZ transgene ectopic expression were observed m
Copyright © 1999 by Academic Press. All rightFigs. 2B, 2D, 2F, and 2H). Therefore, we conclude that the
5 kb MyoD enhancer is not sufficient to activate the de
ryos (A–F) and 12.5-dpc embryos (G–L). In sectioned wild-type
egions (A), in the muscle anlagen of the limb buds (C), and in the
/2:MyoD2/2 embryos, expression was not detected in anterior
lagen in the forelimbs (D) and in areas corresponding to the ventral
served in the posterior neural tube of 11.5-dpc embryos (E and F).
uscle in both the trunk (I) and limbs (K). By contrast, in 12.5-dpc
dorsal medial region located adjacent the dorsal root ganglia (arrow)
forming areas in the limb (L). Note the presence of an analogous
in I and J). Abbreviations: dm, dermomyotome; drg, dorsal rootemb
mal r
yf-52
le an
as ob
of m
in a
scle-novo transcription of MyoD during embryonic develop-
ent.
s of reproduction in any form reserved.
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224 Kablar et al.The 220-kb MyoD Enhancer Is Active at Sites of
Myogenic Determination in Embryos Lacking
Muscle
The 258/22.5lacZ transgene contains the 258-bp core of
the 220-kb MyoD enhancer linked to 2.5 kb of MyoD
roximal promoter sequence and lacZ (Fig. 1). The 258/
22.5lacZ transgene is expressed in a pattern that closely
ollows endogenous MyoD transcription (Goldhamer et al.,
992, 1995; Faerman et al., 1995). Importantly, the 2.5-kb
roximal promoter linked to lacZ displays no detectable
ctivity in transgenic mice, and the 258-bp MyoD enhancer
inked to a heterologous promoter and lacZ is expressed in
similar pattern as 258/22.5lacZ (Goldhamer et al., 1992,
995).
As previously described, in 10.5-dpc wild-type embryos
Fig. 3A), the 258/22.5lacZ transgene was expressed in the
orsal myotomal lip of the somites at and above the
horacic level (green arrows), in the ventral myotomal lip of
he more caudal somites below the level of the forelimb (red
rrow), and in the muscle anlagen of the limb buds (yellow
rrowhead). In 11.5-dpc wild-type embryos (Fig. 3E), the
ore mature rostral somites displayed a barbell-like distri-
ution of expression joining the dorsal and ventral aspects
f the myotome (green and red arrows, respectively). Strong
xpression was also observed in muscle anlagen of 11.5-dpc
ild-type limb buds (yellow arrowhead in Fig. 3E). By 12.5
nd 13.5 dpc, individual muscle masses were readily dis-
ernible due to abundant lacZ expression in virtually all
keletal muscle (Figs. 3I and 3M). As previously described,
he transgene was ectopically expressed in the nasal pit of
ll embryos (Goldhamer et al., 1995).
The pattern of expression in MyoD2/2 embryos was
irtually identical to wild-type (compare Figs. 3A, 3E, 3I,
nd 3M with Figs. 3B, 3F, 3J, and 3N). By contrast, in
yf-52/2 embryos, the distribution of myotomal expres-
ion was limited to the dorsal and ventral regions with the
ar absent from the barbell pattern typical of wild-type
yotomal regions (compare Figs. 3A, 3E, 3I, and 3M with
igs. 3C, 3G, 3K, and 3O). This deficiency likely reflects the
elay in the development of epaxial (back) musculature
reviously described in the absence of Myf-5 (Braun et al.,
992; Kablar et al., 1997). Therefore, we conclude that the
ctivity of the 220-kb 258-bp enhancer core of MyoD is
argely refractory to the absence of either Myf-5 or MyoD.
In 10.5-dpc Myf-52/2:MyoD2/2 embryos the 258/
2.5lacZ transgene exhibited very weak expression in
audal somitic regions above the hindlimb (Fig. 3D, green
rrows) and no detectable expression in rostral somites or
imb buds (yellow arrowhead). In 11.5-dpc Myf-52/2:
MyoD2/2 embryos, continued weak expression was ob-
served in caudal somitic regions (Fig. 3H, green arrow).
However, robust expression was observed in the limb buds
(Fig. 3H, yellow arrowhead), in areas corresponding to the
presumptive muscle anlagen of 11.5-dpc limb buds (com-
pare Figs. 3E and 3H). By 12.5 and 13.5 dpc, expression was
observed in the dorsal aspect of presumptive myotomal
a
F
Copyright © 1999 by Academic Press. All rightegions (Figs. 3L and 3P, green arrows), whereas somewhat
educed expression was observed in limb buds (Figs. 3L and
P, yellow arrowhead). Expression in the ventral region was
bserved only in 11.5- and 12.5-dpc embryos (Figs. 3H and
L, red arrow). Therefore, we conclude that the 258-bp core
f the 220-kb MyoD enhancer is necessary and sufficient to
espond to the signals that activate the de novo transcrip-
ion of MyoD during embryonic development.
Examination of serially sectioned 11.5-dpc mutant em-
ryos revealed expression only within the ventral aspect of
ermomyotomal regions of newly formed caudal somites at
r below the sacral level (Fig. 4F) and not in the more
ature anterior somites (asterisk in Fig. 4B). Robust expres-
ion was also observed in 11.5-dpc limb buds in areas
orresponding to the presumptive muscle anlagen of 11.5
pc limb buds (compare Figs. 4C and 4D).
Wild-type embryos at 12.5 dpc (Fig. 4G) exhibited exten-
ive expression of lacZ in newly formed musculature in the
runk (Fig. 4I) and limbs (Fig. 4K). In 12.5-dpc Myf-52/2:
yoD2/2, embryos (Fig. 4H), a rosette of lacZ-expressing
ells, representing the dermomyotome lip, was observed
djacent to the dorsal root ganglia (DRG) in the trunk
arrow in Fig. 4J) whereas in the limbs, reduced numbers of
acZ-expressing cells were observed with a dispersed distri-
ution (Fig. 4L). Interestingly, lacZ-expressing cells in the
ermomyotome lip were also observed adjacent to the DRG
n wild-type embryos (arrow in Fig. 4I), suggesting that
yogenic determination continues through later stages of
evelopment.
Myogenic Progenitor Cells Migrate into Myf-52/2:
yoD2/2 Limb Buds
Pax-3 is a member of the paired-box-containing transcrip-
tion factor family and is expressed in a variety of neural and
mesodermal cell types including the myogenic migratory
cells that originate from the ventral–lateral region of the
dermomyotome and migrate to the limb (Williams and
Ordahl, 1994). Embryos lacking Myf-5 display delayed de-
velopment of epaxial musculature in the trunk (Braun et al.,
1992) and normal development of hypaxial musculature in
the limbs (Kablar et al., 1997). By contrast, MyoD2/2
embryos display normal development of epaxial muscula-
ture and delayed development of hypaxial musculature
(Kablar et al., 1997). However, both Myf-52/2 and
MyoD2/2 embryos exhibit normal migration of Pax-3-
expressing myogenic-precursor cells into the limbs.
To determine whether the migration of Pax-3-expressing
cells from the dermomyotome to the limb bud occurred
normally in the absence of both Myf-5 and MyoD, we
erformed whole-mount in situ hybridization with an an-
isense RNA probe generated from the mouse Pax-3 cDNA.
xamination 10.5-dpc embryos hybridized with a Pax-3
robe revealed a normal distribution of Pax-3-expressing
ells migrating from the dermomyotome into the forelimbs
nd hindlimbs in Myf-52/2:MyoD2/2 embryos (compare
igs. 5A and 5B and Figs. 5C and 5D). Inspection of
s of reproduction in any form reserved.
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225Activation of MyoD Transcriptionsectioned compound Myf-5 and MyoD mutant embryos
imilarly revealed a normal pattern of Pax-3-expressing
ells extending from the lateral edge of the dermomyotome
nto the forelimb and hindlimb (not shown). Therefore, we
onclude that Pax-3 induction and the subsequent migra-
ion of myogenic precursors into the limb are unaffected by
he absence of MRF expression.
Premyogenic Cells Are Multipotential in the
Absence of Myf-5 and MyoD
The expression of 258/22.5lacZ in Myf-52/2:MyoD2/2
embryos allows a unique opportunity to examine the fate of
cells that would normally become myogenic precursors as
the long half-life of b-galactosidase protein marks cells that
are no longer actively transcribing lacZ (Tajbakhsh et al.,
1996). If the expression of Myf-5 and MyoD defines myo-
genic determination, then cells that normally become myo-
genic precursors should remain multipotential and be found
in tissues other than muscle. Alternatively, if myogenic
determination occurs upstream of the MRFs, lacZ-
expressing cells should not be found in other tissues.
Examinations of sections through 11.5 dpc Myf-52/2:
MyoD2/2 embryos revealed lacZ-positive cells in the ver-
tebral (Fig. 6A), rib (Fig. 6C), and humeral (Fig. 6E) primor-
dia. Importantly, expression of lacZ was never detected in
the primordia of vertebra, rib, and humerus in 11.5 dpc
wild-type embryos (Figs. 6B, 6D, and 6F). At the upper
thoracic level of mutant embryos, lacZ-expressing cells
were clearly detectable in the region of sclerotomal verte-
bral body condensation (compare Fig. 6A with Fig. 6B;
arrowheads delineate the vertebral body condensation bor-
der) and in the region of sclerotomal rib condensation
(compare Fig. 6C with Fig. 6D; arrowheads delineate the rib
condensation border). In the limbs, cells expressing
b-galactosidase were clearly evident in the proximal
epiphysis of the humeral mesenchymal condensation (com-
pare Fig. 6E with Fig. 6F; arrowheads delineate the humeral
mesenchymal condensation border) and in the dermis (not
shown) in 11.5-dpc Myf-52/2:MyoD2/2 embryos.
Double labeling of matched wild-type and Myf-52/2:
MyoD2/2 sections of 12.5-dpc embryos with anti-fetal
cartilage proteoglycan antibody (Glant et al., 1986) and
b-galactosidase confirmed the identification of the humerus
and rib primordia by morphology and position (Figs. 7A–7F).
Strikingly, lacZ-expressing cells were detected within the
anti-fetal proteoglycan antibody reactive area of the hu-
merus and rib in 12.5-dpc Myf-52/2:MyoD2/2 embryos
Figs. 7D–7F), but not in wild-type humerus and rib (Figs.
A–7C). Moreover, the double staining showed that some
ells clearly exhibited overlapping expression of both lacZ
nd anti-fetal cartilage proteoglycan protein, as evidenced
y a dark brown perinuclear ring (arrowheads in Figs. 6E and
F). Together, these observations suggest that these cells
hanged their position and their identity and entered the
hondrogenic instead of the myogenic lineage. Analogous
xpression of lacZ in ribs and nonmuscle cells has also been
m
M
Copyright © 1999 by Academic Press. All rightbserved in Myf-5-lacZ knock-in mice when cells adopt
nonmyogenic fates in the absence of Myf-5 (Tajbakhsh et
al., 1996). We similarly observed lacZ-expressing cells in
the rib primordia of Myf-52/2 embryos containing the
258/22.5lacZ transgene (not shown). However, no lacZ-
expressing cells were detected in the rib or humerus primo-
dia in MyoD2/2 embryos (not shown). The presence of
lacZ-expressing cells in the cartilage primordia of Myf-52/
2:MyoD2/2 embryos strongly supports the assertion that
premyogenic cells are multipotential in the absence of MRF
expression. Therefore, we conclude that that the commit-
ment of multipotential precursor cells into the myogenic
lineage occurs in the limbs in addition to the somite.
By 13.5 dpc, mutant embryos still expressed lacZ in the
limbs (Fig. 3P). Analysis of serially sectioned mutant em-
bryos revealed that lacZ-expressing cells at this stage of
development were strictly localized adjacent to the precar-
tilage primordium of humerus (Fig. 7J). Double labeling of
matched wild-type and Myf-52/2:MyoD2/2 sections of
13.5-dpc embryos with b-galactosidase and TUNEL detec-
tion system to detect apoptotic nuclei in situ revealed a
massive programmed cell death of cells stained with lacZ in
mutant embryos (arrowheads in Figs. 7K and KL). In wild-
type embryos only a small number of lacZ-expressing cells
were undergoing apoptosis (Figs. 7H and 7I, arrowhead). At
the earlier embryonic ages (between 10.5 and 12.5 dpc)
similarly low numbers of apoptotic cells were observed in
the forelimbs of both wild-type and Myf-52/2:MyoD2/2
embryos (not shown). Therefore, we conclude that by 13.5
dpc, Myf-52/2:MyoD2/2 lacZ-expressing cells are no
longer capable of contributing to the chondrogenic cell
lineage and are eliminated by programmed cell death.
DISCUSSION
The molecular mechanisms leading to the de novo induc-
tion of Myf-5 and MyoD transcription in an uncommitted
progenitor cells during development has remained a central
problem in myogenesis. However, several upstream signal-
ing pathways have been implicated as positively or nega-
tively effecting the de novo induction of Myf-5 and MyoD
ranscription. For example, Shh expressed in the floor plate
nd the notochord and Wnt family members expressed in
he dorsal neural tube combinatorially activate myogenesis
n the somite (Munsterberg et al., 1995). Wnts positively
timulate myogenesis in the somite whereas Shh is be-
ieved to activate Noggin expression in the dorsal somite,
nd Noggin inhibits the negative activity of lateral-plate-
erived BMP4 on myogenesis (Hirsinger et al., 1997; Mar-
elle et al., 1997; Reshef et al., 1998). Notch signaling
athways also appear to exert negative effects on myogen-
sis (Kopan et al., 1994; Shawber et al., 1996). Although
hese pathways have been demonstrated to exert effects on
he timing and patterning of myogenesis, the molecular
echanisms that activate the de novo transcription of
yf-5 and MyoD are completely unknown.
s of reproduction in any form reserved.
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226 Kablar et al.The 258-bp core of the 220-kb MyoD enhancer contains
E-boxes and a possible AP1 site, but no other recognizable
motifs (Goldhamer et al., 1995). Presumably, the effectors
of the signaling pathways that regulate the induction of
myogenic determination indirectly or directly activate the
transcription of MyoD through the 220-kb MyoD enhancer.
For example, Shh via its receptor patched, stimulates the
nuclear translocation and hence activity of the Gli family of
zinc-finger transcription factors (Hynes et al., 1997; Lee et
al., 1997). BMPs bind and activate heteromeric complexes
of type I and type II serine/threonine kinase receptors
resulting in the phosphorylation and activation of the Smad
family of transcriptional regulators (Kretzschmar et al.,
998). Wnt signaling stimulates the nuclear association of
b-catenin with the Tcf family of transcription factors (Ko-
FIG 5. Migration of Pax-3 myogenic precursors into the limbs
whole-mount 10.5-dpc wild-type (A, B) and Myf-52/2:MyoD2/2 (
of distribution of Pax-3-expressing cells undergoing migration into
of forelimb buds of wild type and compound mutant is shown in B
FIG. 6. Presumptive myogenic precursor cells become localized
1.5-dpc Myf-52/2:MyoD2/2 embryos, lacZ-positive cells were de
n E) primordia. Analogous sections from wild-type embryos revea
reas (arrows) and never in the primordia of vertebra (B), rib (D), or hu
umeral (E, F) primordia borders.
Copyright © 1999 by Academic Press. All rightinek et al., 1998). Whether Gli factors, Smads, or Tcfs
nteract with the 258-bp core of the 220-kb MyoD enhancer
emains to be addressed.
Morphological studies and quail–chick transplantation
xperiments have lead to the hypothesis that skeletal
uscle of the body proper and the limbs is derived from
yogenic precursor cells that are determined exclusively in
he somite (Hauschka, 1994; Ordahl and Le Douarin, 1992;
ossu et al., 1996). Somites arise as condensations of
paraxial mesoderm, which form epithelial spheres on either
side of the neural tube. The ventral portion of the somite
partitions into a structure called the sclerotome that gives
rise to the cartilage and bone of the trunk. The dorsal–
lateral portion of the somite gives rise to the dermomyo-
tome which partitions into the dermotome and myotome.
urs normally in Myf-52/2MyoD2/2 embryos. Examination of
embryos hybridized with a Pax-3 probe revealed a normal pattern
forelimbs (arrowheads) and in the dermomyotome (arrows). Detail
D, respectively.
eas of precartilage in embryos lacking both Myf-5 and MyoD. In
d in vertebral (arrows in A), rib (arrows in C), and humeral (arrows
xpression of the 258/22.5lacZ transgene only in muscle-formingocc
C, D)to ar
tecte
led emerus (F). Arrowheads delineate vertebral (A, B), rib (C, D), and
s of reproduction in any form reserved.
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228 Kablar et al.The dermomyotome is believed to be the source of all
skeletal myogenic precursor cells within the segmented
region of the developing embryo and each somite gives rise
to between 30 and 100 migratory myogenic precursor cells
(Ordahl and Le Douarin, 1992; reviewed by Hauschka, 1994;
Christ and Ordahl, 1995). However, our observations that
258/22.5lacZ is expressed in both the trunk and the limbs
of Myf-52/2:MyoD2/2 embryos, and that lacZ-expressing
cells become associated with nonmuscle tissues in the
absence of myogenesis, strongly suggest that myogenic
determination occurs in the somites and the limb buds.
It can be argued that the developing limb bud forms a
secondary axis in which many of the morphogens and
regulators of pattern formation that act axially, are simi-
larly expressed, and presumably exert similar effects. For
example, sonic hedgehog (Shh) is expressed in the noto-
chord and floor plate in the trunk where it functions in
induction of motor neurons and patterning of the scle-
rotome and dermomyotome (Roelink et al., 1995; Fan and
Tessier-Lavigne, 1994). Expression of Shh in the notochord/
floorplate synergistically acts with Wnt family members
expressed in the dorsal neural tube to induce MRF expres-
sion in the myotome (Munsterberg et al., 1995). Shh is also
expressed in the zone of polarizing activity (ZPA) of the
early limb bud and mediates the polarizing activity of the
ZPA (Riddle et al., 1993; Marti et al., 1995). Wnt7a is
expressed in the dorsal limb ectoderm where it plays a role
in dorsoventral patterning (Parr and McMahon., 1995).
Moreover, similar analogies can be drawn from the expres-
sion and activities of Bmp4, Fgf8, and twist bHLH factor in
the patterning of axial structures and the developing limb
bud (Cohn and Tickle, 1996; Fuchtbauer, 1995; Spicer et al.,
1996). Taken together, these data are consistent with the
notion that the cells within the developing limb bud
undergo extensive inductive interactions to generate the
variety of mesenchymal derivatives found in the limb.
Clearly, our data support the assertion that the determina-
tion of myogenic precursor cells occurs independently in
the limbs and trunk.
Myogenic precursors migrating into the limb express
Pax-3, a paired-box transcription factor (Williams and Or-
dahl, 1994), but do not express Myf-5 and MyoD until well
after arriving in the limb bud (Sassoon et al., 1989; Tajba-
khsh and Buckingham, 1994; Williams and Ordahl, 1994).
Myogenic precursors fail to migrate in Pax-32/2 or Splotch
embryos resulting in limbs without muscle (Bober et al.,
1994; Goulding et al., 1994; Kothary et al., 1993). Pax-3-
FIG. 7. In the absence of Myf-5 and MyoD presumptive myogenic
and the remaining cells undergo apoptosis by 13.5 dpc. Double sta
tains areas of precartilage (brown-red staining in A–F), revealed co
nd rib (F) primordia only in Myf-52/2:MyoD2/2 12.5-dpc em
b-galactosidase and TUNEL, which detects apoptosis in situ (ar
yf-52/2:MyoD2/2 13.5-dpc embryos and only a few (arrowhead in I)
rimordia.
Copyright © 1999 by Academic Press. All rightexpressing myogenic cells were thought to be determined
(i.e., monopotential) because in avian grafting experiments
as well as in vitro studies, these cells primarily differentiate
into muscle (Tajbakhsh and Buckingham, 1994; Christ and
Ordahl, 1995). Recent experiments have indicated that
Pax-3 plays an essential function leading to the activation
of MyoD transcription during development (Maroto et al.,
997; Tajbakhsh et al., 1997; reviewed by Borycki and
merson, 1997). Consistent with such an upstream role for
ax-3, we observed normal Pax-3 expression in cells migrat-
ng into the limbs of Myf-52/2:MyoD2/2 embryos.
Presumptive myogenic cells expressing b-galactosidase
ere observed to assume nonmuscle fates in the trunk and
he limbs of Myf-52/2:MyoD2/2 embryos. This data
trongly support the assertion that that Pax-3-expressing
resumptive myogenic cells migrating into the limb remain
ultipotential in the absence of both Myf-5 and MyoD. The
ax-3-expressing myogenic precursors are believed to be-
ome determined in the somite prior to arriving in the limb
nd inducing expression of Myf-5 and MyoD (Christ and
rdahl, 1995). Our data contradict this hypothesis and
uggest that Pax-3-expressing migratory cells are in fact
ultipotential until myogenic factor expression is induced.
herefore, we interpret our experiments to suggest that
yf-5 and MyoD expression defines myogenic determina-
ion.
The spatial–temporal expression pattern of 258/22.5lacZ
n Myf-52/2:MyoD2/2 embryos suggests that the MRF-
ndependent activity of the 220-kb MyoD enhancer forms
the basis of the MyoD-dependent myogenic program. Em-
bryos deficient for Myf-5 display about a 2.5-day delay in
he onset of myogenesis in axial muscles whereas the
evelopment of muscles in the limbs and branchial arches
ccurs normally (Kablar et al., 1997). The pattern of MyoD-
ependent myogenesis observed in 11.5-dpc Myf-52/2 em-
bryos is analogous to the pattern of expression of the
258/22.5lacZ transgene in Myf-52/2:MyoD2/2 embryo-
genesis. In 11.5-dpc muscle-deficient mutant embryos, ro-
bust expression of 258/22.5lacZ was observed in the limb
buds in areas corresponding to the presumptive muscle
anlagen, and little or no expression was observed in the
trunk. By 12.5 dpc, expression was initiated in the dorsal
aspect of presumptive myotomal regions. Therefore, we
conclude that the expression pattern of 258/22.5lacZ in
mutant embryos lacking muscle recapitulates the normal
pattern of MyoD induction during embryogenesis as re-
ursor cells can enter the chondrogenic cell lineage before 12.5 dpc
with b-galactosidase and anti-fetal proteoglycan antibody, which
ssion of lacZ and proteoglycan (arrowheads) in the humeral (D, E)
s and never in wild-type embryos (AC). Double staining with
eads), revealed lacZ/TUNEL-positive cells (arrowheads) only inprec
ining
expre
bryo
rowh
in wild-type embryos. Abbreviations; r, rib primordia; h, humeral
s of reproduction in any form reserved.
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230 Kablar et al.vealed by the pattern of myogenesis in Myf-52/2 embryos
Kablar et al., 1997).
The pattern of Myf-5-dependent myogenesis is markedly
ifferent in MyoD-mutant embryos. Embryos lacking
yoD display normal development of paraspinal and inter-
ostal muscles in the body proper, and a 2.5-day delay in
uscle development in limb buds and branchial arches
Kablar et al., 1997). Uncommitted mesenchymal stem cells
re recruited into the myogenic lineage following the inde-
endent transcriptional activation of either Myf-5 or MyoD
Rudnicki and Jaenisch, 1995; Cossu et al., 1996). Taken
ogether, these observations lead to the prediction that the
attern of myogenesis in MyoD2/2 embryos reflects the
patial–temporal pattern of de novo activation of Myf-5
ranscription. Clearly, it will be of interest to identify and
haracterize the Myf-5 regulatory elements that function
nalogously to the 220-kb MyoD enhancer.
Our observations indicate that the 258-bp core of the
20-kb MyoD enhancer is sufficient to activate the de novo
nduction of MyoD transcription during development. The
patial–temporal pattern of 258/22.5lacZ expression in the
imbs and trunk in Myf-52/2:MyoD2/2 embryos suggests
hat the mechanism of transcriptional activation of MyoD
ay differ between the trunk and limbs and perhaps reflects
ntrinsic differences between the Myf-5-dependent and
yoD-dependent myogenic programs (Kablar et al., 1997).
learly, mutational analysis of putative binding sites
ithin the 258-bp enhancer should elucidate our under-
tanding of upstream factors that function in myogenic
nduction and the nature of the molecular mechanisms that
ctivate the myogenic program during embryonic develop-
ent.
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